In summary, although the efficacy of Ginsenoside in improving insulin sensitivity is questionable, ginsenosides show strong potential for regulating glucose and lipid metabolism, and thus conferring metabolic benefits on obesity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.